INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 456m ago
House PTR56m ago
SEC 13F55m ago
Robinhood Chain55m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MD
McWhorter DorriDirector
LWAYLifeway Foods, Inc.
Grant or award
A—
2,512 sh
Dec 30, 2025Dec 31, 2025
Page 1596 of 1855
← PrevNext →
traded Dec 30, 2025
+1d
SEC Form 4

Evidence

9
LP
Lowry Robert PaulDirector
UMACUnusual Machines, Inc.
Option exercise
M—
32.9K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

9
DC
Dalto Juan CarlosDirector
LWAYLifeway Foods, Inc.
Grant or award
A—
2,512 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

9
SJ
Sim JudithDirector
FTNTFortinet, Inc.
Option exercise
M—
649 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC Form 4

Evidence

9
CA
Chitale AparnaCPO & EVP, Customer Operations
SPCEVirgin Galactic Holdings, Inc
Tax withholding
F$482
153 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

9
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M—
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC Form 4

Evidence

9
AT
Ahrens Douglas TChief Financial Officer
SPCEVirgin Galactic Holdings, Inc
Tax withholding
F$2,334
741 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

9
CA
Colglazier Michael ADirector, CEO and President
SPCEVirgin Galactic Holdings, Inc
Tax withholding
F$2,511
797 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

9
CP
Caiano Nicola PaulDirector
ORBSEightco Holdings Inc.
Grant or award
A—
50.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

9
PE
Patterson Martin EdwardDirector
SCORCOMSCORE, INC.
Option exercise
M—
10.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

9
WT
Wiemann Bradley TPresident and CEO
DAKTDAKTRONICS INC /SD/
Option exercise
M$9,338
1,250 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

8
FS
Fendley Steven S.President, US Division
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Open-market sale · 10b5-1 plan
SELL$77K
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

6
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$33K
1,168 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$89K
7,303 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$64K
5,326 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$80K
6,571 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

5
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$469K
45.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

5
MA
Mahdessian AraDirector, Chief Executive Officer
TTANServiceTitan, Inc.
Gift
G—
19.0K sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$757K
45.0K sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$745K
45.0K sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC Form 4

Evidence

4
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

3
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Derivative conversion · 10b5-1 plan
C—
32.4K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

3
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
124 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

3
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
45.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$33K
200 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$33K
200 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

2
MA
Mahdessian AraDirector, Chief Executive Officer
TTANServiceTitan, Inc.
Derivative conversion
C—
19.0K sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

2
MA
Mahdessian AraDirector, Chief Executive Officer
TTANServiceTitan, Inc.
Derivative conversion
C—
19.0K sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

2
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M$60K
8,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$25K
2,395 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,395 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,605 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1,042
100 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence